Key dates

Abstract submission deadline

31 January 2027, 23:59 UK time

Review decisions

Authors notified by 12 February 2027

Final materials

Final posters, where applicable, and author-approved abstracts due by 26 February 2027

Conference

Wednesday 17 March 2027
Novotel Edinburgh Park

These dates apply to submissions for the Pharmacy in Practice Conference 2027.

Submit your abstract

Submitting an abstract does not register you to attend the conference. Conference attendance is open to UK-registered healthcare professionals. Register separately for the conference. Students, trainees and other contributors who do not meet the attendance criteria may submit work; please contact us to discuss presentation arrangements.

1. How to submit

Use the online research submission form. You may submit an abstract initially and supply your final poster later, if applicable.

Please provide:

• A clear title, author names in publication order and author affiliations.
• The corresponding author’s name, email address, role and organisation.
• The proposed presenting author’s name, role and organisation, or state that this is to be confirmed.
• An editable abstract of up to 300 words, entered directly into the form.
• A separate statement of up to 50 words explaining the value of the work for pharmacy and what others can learn from it.
• The project type, submission theme, stage of work and preferred presentation format.
• Relevant references and the declarations requested in the form.

Abstract structure

Use these headings within the 300-word total: Background and aims; Methods; Results; Conclusions. In your conclusions, explain the implications for pharmacy practice.

The title, authors, affiliations, references and declarations are excluded from the abstract word limit. The separate 50-word value statement is also outside this limit. Include key references in Vancouver style in the references field.

Submission themes

Select the theme that best fits your work:

• Better outcomes and safer care
• Access, prevention and inequalities
• People, education and workforce
• Services, collaboration and resources

Completed work and work in progress

Both are welcome. For work in progress, describe the findings available and clearly identify what remains incomplete. Present balanced findings and acknowledge limitations.

Presentation format and posters

You may request a digital poster, a short oral presentation or either format. The final format will be allocated following review and subject to programme availability.

A finished poster is optional at the initial submission stage. If supplied, upload one single-page PDF, no larger than 10 MB, in portrait or landscape format and readable on screen. Accepted poster presenters must supply the final PDF by 26 February 2027.

2. Review and acceptance

Submissions will undergo editorial review for relevance, clarity, methodological quality and integrity. Revisions may be requested. Submission does not guarantee acceptance or your preferred presentation format.

Work should present balanced findings, including limitations. Promotional material will not be accepted. Authors will be notified of review decisions by 12 February 2027.

3. Journal and online publication

Accepted work will appear as an abstract in the Pharmacy in Practice Journal and online, with a link to the accompanying digital poster where supplied.

Authors will approve the final abstract before publication. Final posters, where applicable, and author-approved abstracts must be supplied by 26 February 2027.

This is publication as a conference abstract. Acceptance does not constitute endorsement of the findings by Pharmacy in Practice.

4. Author responsibilities

The submitting author must obtain approval from all co-authors and any necessary employer or rights-holder permissions. Authors remain responsible for the accuracy, originality and integrity of their work.

Disclose previous, concurrent or planned submission, presentation or publication, including relevant dates and restrictions. Authors must check the requirements of other conferences and publishers and ensure that presentation and publication through Pharmacy in Practice are permitted.

5. Ethics and confidentiality

State the project type and relevant ethical or organisational approvals, including reference numbers where applicable, or explain why approval was not required. Audit and service evaluation must meet applicable local governance requirements.

Submissions must not contain identifiable patient or participant information.

6. Funding and transparency

Declare funding, sponsorship and relevant conflicts of interest, or state that there are none.

Describe any use of generative artificial intelligence in preparing the submission or conducting the work, including the tools used and their purpose, or state that none was used. Authors must verify all content.

7. Permission to publish

Copyright remains with the existing rights holder. By submitting, you confirm authority to grant Gen X Media Ltd, trading as Pharmacy in Practice, a non-exclusive, royalty-free licence to publish, display and archive the accepted abstract and poster in the journal and online, with author attribution.

Author names and affiliations will be published. Contact details will not be published without permission. Please read our privacy policy for information about how personal data is handled.

8. Corrections and withdrawal

Notify Pharmacy in Practice promptly of errors or withdrawal requests. Requests received before publication will be honoured. After publication, corrections or retractions may be necessary; copies already distributed cannot be recalled.

Email johnathan@pharmacyinpractice.uk and quote your abstract title.